PharmaVOICE Podcasts

In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy.Thought Leader: Dick Domann, Vice President, Pharmacy Services, TrialCard Inc.Play podcast

In this episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma.Thought Leader: Patricia Ensor, RPh, Senior Advisor, Kantar HealthPlay podcast

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRAPlay podcast

In this episode, Ms. Ruby discusses how clinical trials are like skydiving, what some of the key challenges are in clinical trials, solving unexpected challenges, and creating a productive and collaborative relationship between CROs and sponsors.Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc.Play podcast

In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring.Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical ResearchPlay podcast

In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders.Thought Leader: Peter Lammers, VP, Strategy, Veeva SystemsPlay podcast

In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates.Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, AdherisPlay podcast

In this episode, we discuss the challenges in pharma regarding workforce management, the growing trend of strategic workforce planning, and how this phenomenon will continue to evolve over the next 5 years.Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc.Play podcast

In this episode, Craig Flanagan and DJ Mitsch talk about a major culture change at Sanofi Pharmaceuticals North America: how they designed it, implemented it, what the results were, and the future of this significant undertaking. This podcast will be of great interest to anyone at a large company who is considering or has decided to implement a powerful culture change.Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventisPlay podcast

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and DevelopmentPlay podcast

In this episode, Mr. O'Grady speaks about immersive learning, what it is, and how it is the best choice for many types of mission-critical training.Thought Leader: Garry O'Grady, SVP and General Manager, Pharmaceutical InstitutePlay podcast

In this episode, Anthony Rotolo talks about creativity in the health and wellness space. We cover the importance of creativity in advertising, how to be creative, and, when used properly, how creativity influences behavior change.Thought Leader: Anthony Rotolo, Chief Creative Officer, TRUE Health + WellnessPlay podcast

In this episode, Stacy Simpson Logan talks about the value of obtaining a CMPP credential for employees and employers as well as the future of the CMPP program. CMPP stands for Certified Medical Publication Professional and is administered by ISMPP, the International Society for Medication Publication Professionals.Thought Leader: Stacy Simpson Logan, Chair, CMPP Board of Trustees President, Waterfall ConsultingPlay podcast

In this episode, Ms. Hammond talks about our aging society and how the industry needs to address its therapies to reflect the differences in age groups, including the old, and the very old.Date Posted: 03/28/2013  Size: 9.6MB  Length: 00:20:52  Thought Leader: Melissa Hammond MSN, GNP, Managing Director, SnowfishPlay podcast

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical DevelopmentPlay podcast

Thought Leader: Joseph Bedford, Ph.D., Director of Marketing, Almac Clinical TechnologiesIn this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.For more information about Almac Clinical Technologies, visit www.almacgroup.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leaders: Chris DeAngelis, VP, Sales, SSI and Jonathan Kay, Head of Healthcare, Penn Schoen BerlandIn this episode, Taren Grom, Editor-in-Chief of PharmaVOICE, leads a discussion that focuses on a recent study on women's views and practices regarding health and health decisions for their families. The study uncovered seven lenses for marketing health to women. You'll come away with new insights into women's actual role as decision makers, caregivers, and medical and financial executives in their families. Plus, you will discover how to apply these new findings to create more effective marketing and market research programs for your brand or franchise.For more information about SSI, visit www.surveysampling.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Gina Isherwood, Ph.D., Regional Brand Director, Kantar HealthIn this episode, Dr. Isherwood shares some insightful research on the Russian people, including their health behaviors and attitudes, as well as the state of the health care system in Russia.For more information about Kantar Health, visit www.kantarhealth.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Erez Lapsker, CEO, MediScriptsIn this episode, Mr. Lapsker discusses how adaptability is necessary to remaining a viable and successful business in an era of regulatory change. He also explains how all forms of marketing to HCPs are not equal.For more information about MediScripts, visit www.mediscripts.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Terry Nugent, Executive Vice President, Sales and Marketing, MMS, Inc.In this episode, Mr. Nugent discusses the challenges of using email in pharmaceutical marketing, as well as some best practices for achieving the highest possible ROI.For more information about MMS, visit www.mmslists.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Anthony D. Slonim, MD, DrPH, Executive Vice President and Chief Medical Officer, Barnabas Health. Sponsored: by CMR InstituteIn this episode, Dr. Slonim discusses ACOs, how they offer a new model for health care, how they create opportunities for biopharmaceutical companies, and how a shift to ACOs would affect all facets of the health care continuum.For more information about CMR Institute, visit www.cmrinstitute.org.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leaders: Steve Hoffman, RPh, Chief Pharmacy Officer, McKesson Patient Relationship Solutions, Lynda Stout, PharmD, Lombard Health Mart PharmacyIn this episode, our experts discuss pharmacy-based patient recruitment programs for clinical trials.For more information about McKesson, visit www.mckesson.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: R.J. Lewis, President & CEO, eHealthcare SolutionsIn this episode, Mr. Lewis discusses how pharma can better connect with HCP audiences using authentication, list matching, and other techniques. He also covers how effective communications can impact prescription writing, and how to overcome hurdles from Medical, Legal, and Regulatory (MLR) departments.For more information about eHealthcare Solutions, visit www.ehealthcaresolutions.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Prof. Claude Wischik, M.D., Ph.D., TauRx TherapeuticsIn this episode, Professor Wischik describes his ongoing journey of research and development for Alzheimer's Disease. This intriguing podcast covers the man, the molecule, and the market.For more information about TauRx Therapeutics, visit www.taurx.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leaders: Jessica Dolfi, MS, Senior Business Consultant, Medidata Solutions Worldwide and Kelly Willenberg, MBA, BSN, CHRC, CHC, Kelly Willenberg, LLCIn this episode, we discuss standard of care in clinical trials, challenges for sites and sponsors, and how standard of care issues affect day-to-day work in trials.For more information about Medidata Solutions Worldwide, visit www.mdsol.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leaders: Jessica Albano, PhD, MPH, Senior Director, Epidemiology, Post Approval & Strategic Services, and Dr. Vikki Brown, Medical Director for the Post-Approval and Strategic Services division of INC Research, Inc.In this episode, our experts discuss the primary challenges regarding women's health in clinical research. They also cover pregnancy registries and lactation studies, as well as available regulatory guidance related to this type of research.For more information about INC Research, visit www.incresearch.com.Play Podcast.For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA InternationalIn this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard.For more information about PRA International, visit www.prainternational.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brandIn this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Chris DeAngelis, Vice President, Strategic Initiatives, SSIIn this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics BiotechIn this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Robert Shecterle, Vice President of Marketing, AravoIn this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology CompanyIn this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Richard Malcolm, CEO, AcurianIn this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, CognizantIn this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPDIn this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Craig Lipset, DIA Conference Chair, Head of Clinical Innovation, Development Operations within Worldwide Research & Development, PfizerIn this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, IdisIn this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Scott Connor, VP of Marketing, AcurianIn this episode, Mr. Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list.For more information about Acurian, visit www.acurian.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thought Leader: Lou Shapiro, Senior VP, Business Development, Tunstall AMAC Life SciencesIn this episode, Mr. Shapiro discusses why patient support programs are valuable, how to start a program, the necessity for delivering personalized information, several critical success factors for a program, and understanding health care from the patient's perspective.For more information about Tunstall AMAC Life Sciences, visit www.phonescreen.com.Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 11/10/2011Size: 6.89MBLength: 00:15:03Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar HealthIn this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 9/28/2011Size: 6.4MBLength: 00:14:07Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrialIn this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 9/13/2011Size: 4.67MBLength: 00:10:13Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brandIn this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 8/31/2011Size: 6.17MBLength: 00:13:29Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare AdvertisingIn this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 8/12/2011Size: 6.17MBLength: 00:13:29Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's AssociationIn this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 6/27/2011Size: 6.37MBLength: 00:13:55Thought Leader: Gary Bartolacci, Senior Account Director, Kantar HealthIn this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 5/31/2011Size: 7.8MBLength: 00:17:03Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical ServicesIn this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 5/31/2011Size: 5.56MBLength: 00:12:09Thought Leader: Tim Dietlin, VP of Alliance Development, INC ResearchIn this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 4/29/2011Size: 7.95MBLength: 00:17:23Thought Leader: Richard Scarbath , Director, Enterprise Accounts, AngelIn this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 4/29/2011Size: 12.0MBLength: 00:26:17Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical ServicesIn this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 3/30/2011Size: 5.95MBLength: 00:13:02Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 1/31/2011Size: 8.78MBLength: 00:19:11Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar HealthIn this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.Play PodcastDownload transcript and white paperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.